TAYLOR STEED: Open Payments
NPI 1700371994 · SAINT JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 48 payments from 18 companies in 2025. Trend: 2023 $1,591 · 2024 $1,318 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $239 |
| GENZYME CORPORATION | 4 | $139 |
| Janssen Biotech, Inc. | 4 | $80 |
| Incyte Corporation | 3 | $69 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $66 |
| Organogenesis Inc. | 3 | $59 |
| LEO Pharma Inc. | 2 | $45 |
| Biofrontera Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| STRATA Skin Sciences, Inc. | 4 | $30 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, OPZELURA, ILUMYA, ADBRY, AMELUZ, RINVOQ.
Industry payments across FL — which companies pay providers there.
